We report on improved high-temperature soft magnetic properties in Fe88−2xCoxNixZr7B4Cu1 nanocrystalline alloys. Substituting 5.5 at. % Co and Ni for Fe enhances the magnetization by 5% at ambient temperature and by 30% at 650 °C. The Curie temperature of the residual amorphous phase is also raised significantly (from 67 °C for x=0 to 298 °C for x=5.5), resulting in low coercivities (<30 A m−1) for Fe77Co5.5Ni5.5Zr7B4Cu1 over the temperature range 50–500 °C. The higher magnetization and Curie temperature as compared with other Fe-based alloys, and smaller Co content as compared with (Fe,Co)-based alloys, make this alloy attractive as an affordable high-temperature soft magnetic material.
In this letter, we report on the achievement of exchange anisotropy magnitude in a nanostructured Mn55Al45 alloy fabricated by rapid solidification with large exchange bias values (HE ≈ 13 kOe at 10 K) and a blocking temperature of TB ∼ 95 K. Field-cooled magnetization loops show a prominent exchange bias for T < TB signaling the simultaneous presence of antiferromagnetic and ferromagnetic phases at these temperatures. Structural probes confirm a majority presence of the high-temperature metastable hexagonal ɛ-MnAl in the as-solidified state with an intriguing double-Bragg peak structure indicative of phase separation. The observed exchange bias is hypothesized to originate from an intimate mixture of antiferromagnetic and nanoscaled ferromagnetic phases or dual mictomagnetic phases, approximating a cluster glass with well-defined variations in the local Mn concentration of the composition and leading to Mn-rich and Mn-poor regions with antiferromagnetic and ferromagnetic characters, respectively.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.